Effects of Social Media Use on Self-esteem, Depressive Symptoms, Psychiatric Morbidity, and Physiological Markers of Stress in Adolescent Psychiatric Patients and Healthy Controls

Overview

About this study

The purpose of this study is to contribute to our understanding of the relationships between social media use in adolescents and psychological development, psychiatric comorbidity, and physiological markers of stress.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Adolescents between the ages of 13 to 17 years
Depressed participants will have a diagnosis of major depressive disorder based on a M.I.N.I. KID interview and a QIDS-A17-C score of 11 or higher (moderate to severe symptoms). Healthy control participants will have no psychiatric diagnosis based on a M.I.N.I KID interview and a QIDS-A17-C score of <6.
Enrolled in school
Adolescent participants must have the capacity to provide informed assent
Parents must have the capacity to provide informed consent
Willingness and ability to adhere to study procedures
Participant will have access to an electronic portable device (e.g. phone, tablet, laptop) with internet capabilities

Exclusion Criteria

Steroid based medication (e.g. corticosteroid inhalers in asthmatic)
Learning or language difficulties that would limit ability to understand verbal or written English instructions as could negate questionnaire results
Imminent suicidal intent
Refusal or withdrawal of consent
Inability or unwillingness to adhere to study procedures

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Paul Croarkin, D.O., M.S.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Paul Croarkin, D.O., M.S.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials